A primer on using pooled shRNA libraries for functional genomic screens

Acta Biochimica et Biophysica Sinica

Volumn 44, Issue 2, 2012, Pages 103-112

  Hu, Guang ^a   Luo, Ji ^b  

^a NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES   (United States)

^b NATIONAL CANCER INSTITUTE   (United States)

Author keywords

pooled screen; RNAi; shRNA library

Indexed keywords

SMALL INTERFERING RNA;

ANIMAL; DNA MICROARRAY; GENE LIBRARY; GENE VECTOR; GENETICS; GENOMICS; HUMAN; HUMAN GENOME; METHODOLOGY; MOUSE; REVIEW; RNA INTERFERENCE; STANDARD; STATISTICS; VALIDATION STUDY;

ANIMALS; GENETIC VECTORS; GENOME, HUMAN; GENOMIC LIBRARY; GENOMICS; HUMANS; MICE; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; RNA INTERFERENCE; RNA, SMALL INTERFERING; VALIDATION STUDIES AS TOPIC;

MAMMALIA;

EID: 84856481543     PISSN: 16729145     EISSN: 17457270     Source Type: Journal    
DOI: 10.1093/abbs/gmr116     Document Type: Review

References (45)

1. Berns K, Hijmans EM, Mullenders J, Brummelkamp TR, Velds A, Heimerikx M and Kerkhoven RM, et al. A large-scale RNAi screen in human cells identifies new components of the p53 pathway. Nature 2004, 428: 431-437.
2. Nicke B, Bastien J, Khanna SJ, Warne PH, Cowling V, Cook SJ and Peters G, et al. Involvement of MINK, a Ste20 family kinase, in Ras oncogene-induced growth arrest in human ovarian surface epithelial cells. Mol Cell 2005, 20: 673-685.
3. Berns K, Horlings HM, Hennessy BT, Madiredjo M, Hijmans EM, Beelen K and Linn SC, et al. A functional genetic approach identifies the PI3K pathway as a major determinant of trastuzumab resistance in breast cancer. Cancer Cell 2007, 12: 395-402.
4. Brummelkamp TR, Fabius AW, Mullenders J, Madiredjo M, Velds A, Kerkhoven RM and Bernards R, et al. An shRNA barcode screen provides insight into cancer cell vulnerability to MDM2 inhibitors. Nat Chem Biol 2006, 2: 202-206.
5. Luo B, Cheung HW, Subramanian A, Sharifnia T, Okamoto M, Yang X and Hinkle G, et al. Highly parallel identification of essential genes in cancer cells. Proc Natl Acad Sci USA 2008, 105: 20380-20385.
6. Cheung HW, Cowley GS, Weir BA, Boehm JS, Rusin S, Scott JA and East A, et al. Systematic investigation of genetic vulnerabilities across cancer cell lines reveals lineage-specific dependencies in ovarian cancer. Proc Natl Acad Sci USA 2011, 108: 12372-12377.
7. Gumireddy K, Li A, Gimotty PA, Klein-Szanto AJ, Showe LC, Katsaros D and Coukos G, et al. KLF17 is a negative regulator of epithelial- mesenchymal transition and metastasis in breast cancer. Nat Cell Biol 2009, 11: 1297-1304.
8. Yeung ML, Houzet L, Yedavalli VS and Jeang KT. A genome-wide short hairpin RNA screening of jurkat T-cells for human proteins contributing to productive HIV-1 replication. J Biol Chem 2009, 284: 19463-19473.
9. Hattori H, Zhang X, Jia Y, Subramanian KK, Jo H, Loison F and Newburger PE, et al. RNAi screen identifies UBE2D3 as a mediator of alltrans retinoic acid-induced cell growth arrest in human acute promyelocytic NB4 cells. Blood 2007, 110: 640-650.
10. Schlabach MR, Luo J, Solimini NL, Hu G, Xu Q, Li MZ and Zhao Z, et al. Cancer proliferation gene discovery through functional genomics. Science 2008, 319: 620-624.
11. Luo J, Emanuele MJ, Li D, Creighton CJ, Schlabach MR, Westbrook TF and Wong KK, et al. A genome-wide RNAi screen identifies multiple synthetic lethal interactions with the Ras oncogene. Cell 2009, 137: 835-848.
12. Smogorzewska A, Desetty R, Saito TT, Schlabach M, Lach FP, Sowa ME and Clark AB, et al. A genetic screen identifies FAN1, a Fanconi anemia-associated nuclease necessary for DNA interstrand crosslink repair. Mol Cell 2010, 39: 36-47.
13. Burrows AE, Smogorzewska A and Elledge SJ. Polybromo-associated BRG1-associated factor components BRD7 and BAF180 are critical regulators of p53 required for induction of replicative senescence. Proc Natl Acad Sci USA 2011, 107: 14280-14285.
14. Westbrook TF, Martin ES, Schlabach MR, Leng Y, Liang AC, Feng B and Zhao JJ, et al. A genetic screen for candidate tumor suppressors identifies REST. Cell 2005, 121: 837-848.
15. Bernards R, Brummelkamp TR and Beijersbergen RL. shRNA libraries and their use in cancer genetics. Nat Methods 2006, 3: 701-706.
16. Moffat J, Grueneberg DA, Yang X, Kim SY, Kloepfer AM, Hinkle G and Piqani B, et al. A lentiviral RNAi library for human and mouse genes applied to an arrayed viral high-content screen. Cell 2006, 124: 1283-1298.
17. Root DE, Hacohen N, Hahn WC, Lander ES and Sabatini DM. Genome-scale loss-of-function screening with a lentiviral RNAi library. Nat Methods 2006, 3: 715-719.
18. Chang K, Elledge SJ and Hannon GJ. Lessons from nature: MicroRNA-based shRNA libraries. Nat Methods 2006, 3: 707-714.
19. Paddison PJ, Silva JM, Conklin DS, Schlabach M, Li M, Aruleba S and Balija V, et al. A resource for large-scale RNA-interference-based screens in mammals. Nature 2004, 428: 427-431.
20. Silva JM, Li MZ, Chang K, Ge W, Golding MC, Rickles RJ and Siolas D, et al. Second-generation shRNA libraries covering the mouse and human genomes. Nat Genet 2005, 37: 1281-1288.
21. Ghildiyal M and Zamore PD. Small silencing RNAs: An expanding universe. Nat Rev Genet 2009, 10: 94-108.
22. Cullen BR. Induction of stable RNA interference in mammalian cells. Gene Ther 2006, 13: 503-508.
23. Grimm D, Pandey K and Kay MA. Adeno-associated virus vectors for short hairpin RNA expression. Methods Enzymol 2005, 392: 381-405.
24. Singer O and Verma IM. Applications of lentiviral vectors for shRNA delivery and transgenesis. Curr Gene Ther 2008, 8: 483-488.
25. Stegmeier F, Hu G, Rickles RJ, Hannon GJ and Elledge SJ. A lentiviral microRNA-based system for single-copy polymerase II-regulated RNA interference in mammalian cells. Proc Natl Acad Sci USA 2005, 102: 13212-13217.
26. Wiederschain D, Wee S, Chen L, Loo A, Yang G, Huang A and Chen Y, et al. Single-vector inducible lentiviral RNAi system for oncology target validation. Cell Cycle 2009, 8: 498-504.
27. Shin KJ, Wall EA, Zavzavadjian JR, Santat LA, Liu J, Hwang JI and Rebres R, et al. A single lentiviral vector platform for microRNA-based conditional RNA interference and coordinated transgene expression. Proc Natl Acad Sci USA 2006, 103: 13759-13764.
28. Meerbrey KL, Hu G, Kessler JD, Roarty K, Li MZ, Fang JE and Herschkowitz JI, et al. The pINDUCER lentiviral toolkit for inducible RNA interference in vitro and in vivo. Proc Natl Acad Sci USA 2011, 108: 3665-3670.
29. Gwack Y, Sharma S, Nardone J, Tanasa B, Iuga A, Srikanth S and Okamura H, et al. A genome-wide Drosophila RNAi screen identifies DYRK-family kinases as regulators of NFAT. Nature 2006, 441: 646-650.
30. Schmitz MH, Held M, Janssens V, Hutchins JR, Hudecz O, Ivanova E and Goris J, et al. Live-cell imaging RNAi screen identifies PP2A-B55alpha and importin-beta1 as key mitotic exit regulators in human cells. Nat Cell Biol 2010, 12: 886-893.
31. Friedman A and Perrimon N. A functional RNAi screen for regulators of receptor tyrosine kinase and ERK signalling. Nature 2006, 444: 230-234.
32. Ngo VN, Davis RE, Lamy L, Yu X, Zhao H, Lenz G and Lam LT, et al. A loss-of-function RNA interference screen for molecular targets in cancer. Nature 2006, 441: 106-110.
33. Shaffer AL, Emre NC, Lamy L, Ngo VN, Wright G, Xiao W and Powell J, et al. IRF4 addiction in multiple myeloma. Nature 2008, 454: 226-231.
34. Barbie DA, Tamayo P, Boehm JS, Kim SY, Moody SE, Dunn IF and Schinzel AC, et al. Systematic RNA interference reveals that oncogenic KRAS-driven cancers require TBK1. Nature 2009, 462: 108-112.
35. Scholl C, Frohling S, Dunn IF, Schinzel AC, Barbie DA, Kim SY and Silver SJ, et al. Synthetic lethal interaction between oncogenic KRAS dependency and STK33 suppression in human cancer cells. Cell 2009, 137: 821-834.
36. Vicent S, Chen R, Sayles LC, Lin C, Walker RG, Gillespie AK and Subramanian A, et al. Wilms tumor 1 (WT1) regulates KRAS-driven oncogenesis and senescence in mouse and human models. J Clin Invest 2010, 120: 3940-3952.
37. O'Connell BC, Adamson B, Lydeard JR, Sowa ME, Ciccia A, Bredemeyer AL and Schlabach M, et al. A genome-wide camptothecin sensitivity screen identifies a mammalian MMS22L-NFKBIL2 complex required for genomic stability. Mol Cell 2010, 40: 645-657.
38. Bivona TG, Hieronymus H, Parker J, Chang K, Taron M, Rosell R and Moonsamy P, et al. FAS and NF-kappaB signalling modulate dependence of lung cancers on mutant EGFR. Nature 2011, 471: 523-526.
39. Smolen GA, Zhang J, Zubrowski MJ, Edelman EJ, Luo B, Yu M and Ng LW, et al. A genome-wide RNAi screen identifies multiple RSK-dependent regulators of cell migration. Genes Dev 2010, 24: 2654-2665.
40. Possemato R, Marks KM, Shaul YD, Pacold ME, Kim D, Birsoy K and Sethumadhavan S, et al. Functional genomics reveal that the serine synthesis pathway is essential in breast cancer. Nature 2011, 476: 346-350.
41. Zender L, Xue W, Zuber J, Semighini CP, Krasnitz A, Ma B and Zender P, et al. An oncogenomics-based in vivo RNAi screen identifies tumor suppressors in liver cancer. Cell 2008, 135: 852-864.
42. Zuber J, Shi J, Wang E, Rappaport AR, Herrmann H, Sison EA and Magoon D, et al. RNAi screen identifies Brd4 as a therapeutic target in acute myeloid leukaemia. Nature 2011, 478: 524-528.
43. Birmingham A, Selfors LM, Forster T, Wrobel D, Kennedy CJ, Shanks E and Santoyo-Lopez J, et al. Statistical methods for analysis of highthroughput RNA interference screens. Nat Methods 2009, 6: 569-575.
44. Xu Q, Schlabach MR, Hannon GJ and Elledge SJ. Design of 240,000 orthogonal 25mer DNA barcode probes. Proc Natl Acad Sci USA 2009, 106: 2289-2294.
45. Fellmann C, Zuber J, McJunkin K, Chang K, Malone CD, Dickins RA and Xu Q, et al. Functional identification of optimized RNAi triggers using a massively parallel sensor assay. Mol Cell 2011, 41: 733-746.